Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stepped-dose versus standard-dose efavirenz for neuropsychiatric tolerability in adults with HIV infection
2005-003243-31Phase 4Active
- Sponsor
- Luis Fernando López Cortés
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Luis Fernando López Cortés. Primary endpoint: Frequency and intensity of neuropsychiatric adverse events attributable to efavirenz. Started Jan 2006; status: active.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-003243-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003243-31.